Human cancer and

PI3K Elevated PI3K has been observed in a variety of human cancers and is implicated in transformation and tumor progression... 

Table 4. Inhibitory concentrations (ICso) of cisplatin and AU55 incubated with various human cancer and healthy cell lines for 72 and 24 h, respectively.

EZH2 is overexpressed in various human cancers and its high expression correlates with poor prognosis in prostate and breast cancers [33,34]. 

G9a, also known as EHMT2, is overexpressed in human cancers and knockdown of G9a inhibits cancer cell growth [35]. In addition, G9a inactivates the tumor suppressor p53 via dimethylation of lysine 373 [22]. 

The main emphasis of research is on epidemiology, environmental carcinogenesis, and research training. lARC is thus different from aU other research institutes, in that it focuses its studies on human cancer and the relationships of man and his environment. 

Mitelman, F. (1984). "Restricted number of chromosomal regions implicated in aetiology of human cancer and leukemia, Nature 310,325. 

Some 3 billion have been spent on researching possible health effects from dioxin, and the results show that the risks were overstated. Last year, the Environmental Protection Agency s Science Advisory Board concluded that the evidence that dioxin is a cause of human cancer and other diseases is unconvincing.3 Furthermore, studies of workers exposed to the highest levels of dioxin ever experienced—levels that will never be seen again— have failed to produce any conclusive evidence of connections between dioxin and cancer4 and the other health effects.5... 

Study of other rare hereditary cancers has led to the location of 20 or more additional probable tumor-suppressor genes. One of these, p53, is inactive in over 50% of all human cancers and over 90% of sqamous cell carcinomas of the skin.ee In small-cell lung cancers and osteosarcoma both RB and p53 are inactive.2 Protein p53 is a stronger tumor suppressor than protein Rb. Results of a variety of experiments have suggested that p53, a DNA-binding protein of known structure, plays a key role in checking DNA for damage at the C,... 

More than 95% of the alterations in the p53 gene are point mutations that produce the mutant p53 protein, which in most cases has lost its transactivational activity, resulting in loss of tumor suppressor activity. p53 is the most commonly mutated gene in human cancers, and such a gene is involved in the development of at least 50% of clinical tumors (Damton, 1998). 

Ang WH, Grote Z, Scopelliti R, Juillerat-Jeanneret L, Several K, Dyson PJ (2009) Organometallic complexes that interconvert between trimeric and monomeric structures as a function of pH and their effect on human cancer and fibroblast cells. J Organomet Chem 694 968-972... 

As of today, expression proteomic studies are available for all common human cancers and some rare tumors. 

---